EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

PNPLA3 I148M Interacts With Environmental Triggers to Cause Human Disease

Elizabeth K Speliotes iD, Carolin Victoria Schneider iD

Liver International · 2025

DOI: 10.1111/liv.16106 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Liver International, 2025. Verfasst von Elizabeth K Speliotes und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Lipase, Membrane Proteins, Gene-Environment Interaction, Fatty Liver. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, Interdisciplinary Centre for Clinical Research within the faculty of Medicine at the RWTH Aachen University, CSR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic dysfunction‐associated steatotic liver disease (MASLD) affects up to 30% of Western populations. While obesity is a recognized risk factor, MASLD does not develop in all obese individuals, highlighting the need to understand genetic and environmental interactions. The PNPLA3 I148M variant has been identified as a key genetic risk factor, significantly increasing the likelihood of MASLD development and progression.

Methods

We reviewed current literature on the role of PNPLA3 I148M in MASLD, focusing on gene‐environment interactions involving diet, physical activity, obesity, and insulin resistance. We included studies analysing ethnic differences in PNPLA3 I148M prevalence and its association with MASLD. Additionally, we reviewed data on how PNPLA3 I148M influences the response to therapies, including lipid‐lowering medications and GLP‐1 agonists.

Results

The PNPLA3 I148M variant markedly heightens MASLD risk, particularly in Hispanic populations, where a higher prevalence of MASLD is observed. Lifestyle factors such as high sugar intake, alcohol consumption, and physical inactivity exacerbate MASLD risk among I148M carriers. Evidence shows that insulin resistance amplifies MASLD risk associated with the I148M variant, especially in non‐diabetic individuals. Moreover, the PNPLA3 I148M variant interacts with other genetic loci, further modifying MASLD risk and disease course. The variant also influences treatment response, with variability observed in effectiveness of lipid‐lowering therapies and GLP‐1 agonists among carriers.

Conclusion

The interplay between PNPLA3 I148M and environmental factors underscores the need for personalized MASLD prevention and treatment strategies. Targeting both genetic and lifestyle contributors may enhance MASLD management, offering a tailored approach to reducing disease burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipaseMembrane ProteinsGene-Environment InteractionFatty LiverHumansInsulin ResistanceGenetic Predisposition to DiseaseObesityRisk FactorsLife StyleDietExerciseAcyltransferasesPhospholipases A2, Calcium-Independent

Stichwörter der Autor:innen

MASLDPNPLA3gene–environment interactionliver disease progressionpersonalised therapy

Substanzen

LipasePNPLA3 protein, humanMembrane ProteinsAcyltransferasesPhospholipases A2, Calcium-Independent

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Gastroenterology, Endocrinology and Intensive Care, RWTH Aachen University, Aachen, Germany.

ORCID-Profile: Elizabeth K Speliotes, Carolin Victoria Schneider

Förderung

  • NIDDK NIH HHS
  • Interdisciplinary Centre for Clinical Research within the faculty of Medicine at the RWTH Aachen University
  • CSR NIH HHS
  • Deutsche Forschungsgemeinschaft
  • NRW Rueckkehr Programme of the Ministry of Culture and Science of the German State of North Rhine-Westphalia
  • The University of Michigan Department of Internal Medicine and the University of Michigan MBIOFar Program
  • Junior Principal Investigator Fellowship program of RWTH Aachen Excellence strategy
  • Center for Scientific Review

Zitieren

APA

Speliotes, E. K., & Schneider, C. V. (2025). PNPLA3 I148M Interacts With Environmental Triggers to Cause Human Disease. Liver International. https://doi.org/10.1111/liv.16106

Vancouver

Speliotes EK, Schneider CV. PNPLA3 I148M Interacts With Environmental Triggers to Cause Human Disease. Liver International. 2025. doi:10.1111/liv.16106

BibTeX
@article{Speliotes2025,
  author = {Speliotes, Elizabeth K and Schneider, Carolin Victoria},
  title = {PNPLA3 I148M Interacts With Environmental Triggers to Cause Human Disease},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.16106}
}
Kostenlos starten →